search
Piramal has over 30 years of experience in supporting customers with drug product development, manufacturing and packaging. The combination of our experience and a globally integrated network of facilities enables us to rapidly progress your unique drug product from early development stage to commercial launch.
With a client base that includes large and small pharma, biotech’s, animal health, academic and government institutions, our Sellersville facility in USA has expertise in development, manufacture, and packaging of potent and controlled substances and is approved by the USFDA and EMA. Successfully completed DEA general inspection in February 2021.
We routinely specialize in formulating highly toxic compounds such as hormones and steroids into safe and effective oral solids, liquid or lyophilized drug products. Our site at Morpeth, UK has expertise specializing in the manufacturing, packaging and testing of general oral solid formulations & hormonal products.
Our facilities' extensive experience with Antibody Drug Conjugates (ADCs), bio-conjugates, and peptides positions us exceptionally well to serve our customers in these specialized categories. We excel in the complex processes required for the development and manufacturing of these advanced therapies, ensuring high efficacy and safety. Additionally, through our associate company Yapan Bio, we expanded our capabilities to include the development and manufacturing of vaccines and biologics, further enhancing our comprehensive service.
Piramal is a global leader in delivering customer centric solutions in the world of Antibody Drug Conjugates (ADCs) and Bioconjugates to global pharma and biopharma companies alike. Our world class facilities in UK and US, backed by a highly experienced team, offer integrated services, from conjugation to Clinical and Commercial ADC GMP Batch Manufacturing and Fill/ Finish.
Piramal offers development and manufacturing services for large molecules through our associate company Yapan Bio. Based in Hyderabad, India, Yapan Bio has a proven track record in the successful development and manufacturing of various large molecules. Yapan specializes in process development, scale-up, and GMP-compliant manufacturing of vaccines and biologics, including high-containment product classes (up to BSL-2+), recombinant vaccines, viral vector-based vaccines, gene therapies, monoclonal antibodies, therapeutic proteins, and other complex biologics for Phase I/II human clinical trials.
Piramal’s Turbhe facility specializes in the development and commercial manufacturing of peptides using both solution and solid-phase synthesis methods. Additionally, we provide a range of generic peptide APIs from multigram to kilogram scale. Our facility holds accreditations from USFDA, EDQM, AIFA, and KFDA.